Last reviewed · How we verify
NCT06596863
Serum Uromodulin and DN Systematic Review and Meta Analysis
trial testing The association of serum uromodulin with DN in Diabetic Nephropathies in 1,774 participants. Completed in 30 May 2024.
30 May 2024
Quick facts
| Lead sponsor | Tanta University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,774 |
| Start date | 1 May 2024 |
| Primary completion | 30 May 2024 |
| Estimated completion | 30 May 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- The association of serum uromodulin with DN
- The DN patients were divided according to the level of albumin to creatinine ratio (ACR), glomerular filtration rate (GFR), or albumin excretion rate (AER) in patients with DN
Conditions studied
- Diabetic Nephropathies — all drugs for Diabetic Nephropathies →
Sponsor
Tanta University
Who can join
Eligibility, any sex, with Diabetic Nephropathies. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Several studies have investigated the association between the changes of serum uromodulin and diabetic nephropathy (DN). However, the results are still controversial. Hence, this meta-analysis aimed to evaluate the association of uromodulin with DN.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Association of serum uromodulin with diabetic kidney disease: a systematic review and meta-analysis.
Barr SI, Abd El-Azeem EM, Bessa SS, Mohamed TM. · · 2024 · cited 3× · PMID 39581971 · DOI 10.1186/s12882-024-03854-x
Verify or expand the search:
- PubMed search for NCT06596863
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetic Nephropathies
Currently open trials in the same condition.
- NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting
- NCT07187713 — ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases · Phase 4 · recruiting
- NCT06778018 — Nutritional Outcomes of Lotus Seed (Nelumbo Nucifera) on Diabetic Sensorimotor Polyneuropathy · NA · recruiting
- NCT06441591 — Clinical Outcome of Vinpocetine in Diabetic Nephropathy · Phase 2, PHASE3 · recruiting
- NCT06431477 — Efficacy and Safety of Telmisartan Compared With Losartan · Phase 4 · recruiting
Other Tanta University trials
Trials by the same sponsor.
- NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
- NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
- NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
- NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
- NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06596863 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tanta University
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06596863.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing